why choose us

First received: February 06, 2023

Clinical Trial: A Study to Test How Well Different Doses of BI 765250 Are Tolerated by People With a Skin Disease Called Plaque Psoriasis

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Psoriasis

Study Type: INTERVENTIONAL


Official Title: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intravenous and Subcutaneous Multiple Rising Doses of BI 765250 Versus Placebo in Trial Participants With Moderate to Severe Plaque Psor

Brief Summary: This study is open to adults with plaque psoriasis.The main purpose of this study is to find out whether people with plaque psoriasis can tolerate a medicine called BI 765250.Another purpose is to check whether BI 765250 can improve participants' skin condition.Participants are divided into 5 groups.Each group gets a different dose of BI 765250 or placebo as an infusion or injection for 12 weeks.Placebo infusions and injections look like BI 765250 but do not contain any medicine.It is decided by chance, who…

Read more